- Home
- FRD vs LUCD Comparison
FRD vs LUCD Comparison
Compare FRD & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRD
- LUCD
- Stock Information
- Founded
- FRD 1965
- LUCD 2018
- Country
- FRD United States
- LUCD United States
- Employees
- FRD N/A
- LUCD N/A
- Industry
- FRD Steel/Iron Ore
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FRD Industrials
- LUCD Health Care
- Exchange
- FRD Nasdaq
- LUCD Nasdaq
- Market Cap
- FRD 114.4M
- LUCD 108.0M
- IPO Year
- FRD N/A
- LUCD 2021
- Fundamental
- Price
- FRD $21.14
- LUCD $1.22
- Analyst Decision
- FRD
- LUCD Strong Buy
- Analyst Count
- FRD 0
- LUCD 5
- Target Price
- FRD N/A
- LUCD $3.70
- AVG Volume (30 Days)
- FRD 22.9K
- LUCD 1.4M
- Earning Date
- FRD 11-11-2025
- LUCD 11-12-2025
- Dividend Yield
- FRD 0.76%
- LUCD N/A
- EPS Growth
- FRD N/A
- LUCD N/A
- EPS
- FRD 1.21
- LUCD N/A
- Revenue
- FRD $464,826,000.00
- LUCD $4,360,000.00
- Revenue This Year
- FRD N/A
- LUCD $13.90
- Revenue Next Year
- FRD N/A
- LUCD $163.88
- P/E Ratio
- FRD $16.75
- LUCD N/A
- Revenue Growth
- FRD N/A
- LUCD 14.74
- 52 Week Low
- FRD $12.24
- LUCD $0.75
- 52 Week High
- FRD $22.98
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- FRD 47.15
- LUCD 48.06
- Support Level
- FRD $20.80
- LUCD $1.00
- Resistance Level
- FRD $22.54
- LUCD $1.07
- Average True Range (ATR)
- FRD 0.80
- LUCD 0.03
- MACD
- FRD -0.39
- LUCD 0.00
- Stochastic Oscillator
- FRD 16.54
- LUCD 57.14
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.